TwoStep Therapeutics
A versatile integrin-binding peptide, PIP
TwoStep Therapeutics is active in the nfx portfolio space, founded in 2023.
TwoStep Therapeutics is positioned in nfx portfolio, a segment that rewards a clear, focused offering.
It is recorded at the Seed stage.
| Sector | NFX portfolio |
|---|---|
| Founded | 2023 |
| Stage | Seed |
Website: www.twosteptx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account